CES1 is the major hydrolytic enzyme responsible for the biotransformation of many and diverse therapeutic agents including Angiotensin-converting-enzyme inhibitors, anti-cancer prodrugs, narcotic drugs, methylphenidate, and others. The gene discussed is ACE; the disease is cancer.